Title	Publication Date	Language	Citations
Violence in first-episode psychosis: A systematic review and meta-analysis	2011/02/01	English	205
Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’	2004/12/01	English	205
North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment	2012/12/01	English	203
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia	2011/11/01	English	203
Remediation of impairments in facial affect recognition in schizophrenia: Efficacy and specificity of a new training program	2005/12/01	English	203
MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders	2010/12/01	English	202
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)	2011/11/01	English	202
The prodromal questionnaire (PQ): Preliminary validation of a self-report screening measure for prodromal and psychotic syndromes	2005/11/01	English	201
Psychotic-like experiences and correlation with distress and depressive symptoms in a community sample of adolescents and young adults	2010/06/01	English	200
How sedentary are people with psychosis? A systematic review and meta-analysis	2016/03/01	English	198
Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals	2009/03/01	English	197
Specificity of the Calgary Depression Scale for schizophrenics	1994/02/01	English	196
Social cognition in psychosis: Multidimensional structure, clinical correlates, and relationship with functional outcome	2011/02/01	English	191
Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study	2018/07/01	English	191
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆	2007/02/01	English	191
The burden of depressive symptoms in the long-term treatment of patients with schizophrenia	2007/02/01	English	189
Apoptotic mechanisms and the synaptic pathology of schizophrenia	2006/01/01	English	188
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial	2007/02/01	English	187
GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum	2005/01/01	English	186
Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia	2005/05/01	English	185
Schizophrenia and depression: Challenging the paradigm of two separate diseases—A controlled study of schizophrenia, depression and healthy controls	2005/09/01	English	185
Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people	2006/05/01	English	184
Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study	2004/04/01	English	182
Neurocognitive performance and functional disability in the psychosis prodrome	2006/05/01	English	182
Quantifying incoherence in speech: An automated methodology and novel application to schizophrenia	2007/07/01	English	181
Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia	2014/09/01	English	181
A longitudinal study of neurocognitive function in individuals at-risk for psychosis	2006/12/01	English	180
GABAergic mechanisms of hippocampal hyperactivity in schizophrenia	2015/09/01	English	179
Social functioning in individuals at clinical high risk for psychosis	2008/02/01	English	178
Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia	2006/02/01	English	177